✦ LIBER ✦

In vivo confocal microstructural analysis of corneal endothelial changes in a patient on long-term chlorpromazine therapy

✍ Scribed by Yun Shan Phua; Dipika V. Patel; Charles N. J. McGhee

Book ID: 106096909
Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 114 KB
Volume: 243
Category: Article
ISSN: 0065-6100
DOI: 10.1007/s00417-004-0982-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo observations of chlorpromazine o

In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy

✍ Mohammad Reza Razeghinejad; Mohammad Hosein Nowroozzadeh; Mohammad Zamani; Nima 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Clinical and microstructural analysis of

Clinical and microstructural analysis of patients with hyper-reflective corneal endothelial nuclei imaged by in vivo confocal microscopy

✍ Dipika V. Patel; Yun Shan Phua; Charles N.J. McGhee 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Long-term efficacy of interferon alpha t

Long-term efficacy of interferon alpha therapy on hepatitis B viral replication in patients with chronic hepatitis B: A meta-analysis

✍ Yong-Feng Yang; Wei Zhao; Hai-Ming Xia; Yan-Dan Zhong; Ping Huang; Jian Wen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Effect of interferon therapy on hepatoce

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis

✍ Kenji Ikeda; Satoshi Saitoh; Yasuji Arase; Kazuaki Chayama; Yoshiyuki Suzuki; Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 3 views

The activity of interferon (IFN) is not elucidated from the viewpoint of cancer prevention in chronic hepatitis C patients en masse. The hepatocellular carcinogenesis rate was analyzed statistically in 1,643 patients with chronic hepatitis C: 1,191 patients with IFN therapy and 452 without IFN thera

Impact of long-term Xuezhikang therapy o

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

✍ Jian-Jun Li; Zong-Liang Lu; Wen-Rong Kou; Roberto Bolli; Zuo Chen; Yang-Feng Wu; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB